Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Telenursing for the Early Detection and Management of Side Effects Associated With Cyclin-Dependent Kinase Inhibitors in Breast Cancer Patients [NA]

View source ↗

Summary

A clinical trial is recruiting to evaluate telenursing for early detection and management of side effects in breast cancer patients treated with CDK inhibitors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyclin-dependent kinase 4/6 inhibitors (CDK4/6 inhibitors)

Snippet

Sponsor: Azienda Sanitaria Locale di Asti | Conditions: Breast Cancer, Drug-Related Side Effects and Adverse Reactions | NA | Status: RECRUITING